|
font size Sign in
ECONOMIC DEVELOPMENT:Can the FDA Get California's Biotech Sector Growing Again?Podcast: February 13, 2012 After two decades of steady job growth, employment in California's biomedical industry stalled while the state has struggled to recover from the deep global recession, according to the 2012 California Biomedical Industry Report from the California Healthcare Institute, BayBio, and PwC. We spoke to David Gollaher, CEO of the California Healthcare Institute, about the state of California’s biomedical industry, how companies are coping with the growing risk aversion of investors, and how the regulatory environment in the United States has both companies and investors turning away. Read More ![]()
Industrial/Ag Bio
Public Health
Research and Development
Digital Health
Business Strategy
Trials and Tribulations
Regulatory
Deals
Healthcare Reform
Commentary
![]()
Now Available
The Burrill Report February 2012
Podcast
Fixing Drug Development with the Wisdom of Crowds
Burrill Report Data Center
Finance Scorecard
By the numbers
Two Life Sciences IPOs Debut Below Target
|